Search research articles
Contact Us
Filters
Showing results (331-340 of 342) with videos related to
Page
of 35
Sort By:
The American Journal of Physiology
|
June 1, 1995
ROMK inwardly rectifying ATP-sensitive K+ channel. II. Cloning and distribution of alternative forms
M A Boim, K Ho, M E Shuck, et al.
The Journal of Clinical Investigation
|
May 1, 1976
Permselectivity of the glomerular capillary wall. Studies of experimental glomerulonephritis in the rat using dextran sulfate
C M Bennett, R J Glassock, R L Chang, et al.
Circulation Research
|
May 1, 1984
Renal and systemic hemodynamic responses to intravenous infusion of leukotriene C4 in the rat
K F Badr, C Baylis, J M Pfeffer, et al.
Diabetologia
|
August 6, 2005
Adverse effects of left ventricular hypertrophy in the reduction of endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) study
G Boner, M E Cooper, K McCarroll, et al.
The Journal of Clinical Investigation
|
May 1, 1976
Permselectivity of of the glomerular capillary wall. Studies of experimental glomerulonephritis in the rat using neutral dextran
R L Chang, W M Deen, C R Robertson, et al.
Kidney International
|
June 9, 2000
Renal allograft protection with losartan in Fisher-->Lewis rats: hemodynamics, macrophages, and cytokines
F Ziai, H Nagano, M Kusaka, et al.
Ugeskrift for Laeger
|
October 17, 2001
[Effect of losartan on renal and cardiovascular complications of patients with type 2 diabetes and nephropathy]
H H Parving, B M Brenner, M E Cooper, et al.
The New England Journal of Medicine
|
September 22, 2001
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
B M Brenner, M E Cooper, D de Zeeuw, et al.
Diabetes, Obesity & Metabolism
|
October 30, 2015
Is a reduction in albuminuria associated with renal and cardiovascular protection? A post hoc analysis of the ALTITUDE trial
H J L Heerspink, T Ninomiya, F Persson, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS
|
April 23, 2002
The losartan renal protection study--rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan)
B M Brenner, M E Cooper, D de Zeeuw, et al.
Page
of 35
Search research articles
Search
Showing results (331-340 of 342) with videos related to
Sort By:
Page
of 35
The American Journal of Physiology
|
June 1, 1995
ROMK inwardly rectifying ATP-sensitive K+ channel. II. Cloning and distribution of alternative forms
M A Boim, K Ho, M E Shuck, et al.
The Journal of Clinical Investigation
|
May 1, 1976
Permselectivity of the glomerular capillary wall. Studies of experimental glomerulonephritis in the rat using dextran sulfate
C M Bennett, R J Glassock, R L Chang, et al.
Circulation Research
|
May 1, 1984
Renal and systemic hemodynamic responses to intravenous infusion of leukotriene C4 in the rat
K F Badr, C Baylis, J M Pfeffer, et al.
Diabetologia
|
August 6, 2005
Adverse effects of left ventricular hypertrophy in the reduction of endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) study
G Boner, M E Cooper, K McCarroll, et al.
The Journal of Clinical Investigation
|
May 1, 1976
Permselectivity of of the glomerular capillary wall. Studies of experimental glomerulonephritis in the rat using neutral dextran
R L Chang, W M Deen, C R Robertson, et al.
Kidney International
|
June 9, 2000
Renal allograft protection with losartan in Fisher-->Lewis rats: hemodynamics, macrophages, and cytokines
F Ziai, H Nagano, M Kusaka, et al.
Ugeskrift for Laeger
|
October 17, 2001
[Effect of losartan on renal and cardiovascular complications of patients with type 2 diabetes and nephropathy]
H H Parving, B M Brenner, M E Cooper, et al.
The New England Journal of Medicine
|
September 22, 2001
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
B M Brenner, M E Cooper, D de Zeeuw, et al.
Diabetes, Obesity & Metabolism
|
October 30, 2015
Is a reduction in albuminuria associated with renal and cardiovascular protection? A post hoc analysis of the ALTITUDE trial
H J L Heerspink, T Ninomiya, F Persson, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS
|
April 23, 2002
The losartan renal protection study--rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan)
B M Brenner, M E Cooper, D de Zeeuw, et al.
Page
of 35